# Williams Sonoma Inc: financial statements, quarterly

WSM · NYSE · CIK 719955 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/wsm.md) · [Financials](/companies/wsm/financials.md) · [Filings](/companies/wsm/filings.md) · [Insiders](/companies/wsm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wsm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q4 FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q4 FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,854](/filings/0001628280-24-048978.md) | [2,279 d](/filings/0000719955-26-000059.md) | [1,660](/filings/0001628280-25-028196.md) | [1,788](/filings/0000719955-25-000010.md) | [1,801](/filings/0000719955-25-000049.md) | [2,462 d](/filings/0000719955-26-000059.md) | [1,730](/filings/0000719955-26-000131.md) | [1,837](/filings/0000719955-26-000208.md) | [1,883](/filings/0000719955-25-000049.md) | [2,357 d](/filings/0000719955-26-000059.md) | [1,805](/filings/0000719955-26-000131.md) | [1,960](/filings/0000719955-26-000208.md) |
| Cost of revenue | $m | not reported | not reported | not reported | [984](/filings/0000719955-25-000010.md) | [983](/filings/0000719955-25-000049.md) | [1,297 d](/filings/0000719955-26-000059.md) | [964](/filings/0000719955-26-000131.md) | [972](/filings/0000719955-26-000208.md) | [1,015](/filings/0000719955-25-000049.md) | [1,252 d](/filings/0000719955-26-000059.md) | [1,012](/filings/0000719955-26-000131.md) | [948](/filings/0000719955-26-000208.md) |
| Gross profit | $m | [822](/filings/0001628280-24-048978.md) | [1,049 d](/filings/0000719955-26-000059.md) | [795](/filings/0001628280-25-028196.md) | [804](/filings/0000719955-25-000010.md) | [818](/filings/0000719955-25-000049.md) | [1,166 d](/filings/0000719955-26-000059.md) | [766](/filings/0000719955-26-000131.md) | [865](/filings/0000719955-26-000208.md) | [868](/filings/0000719955-25-000049.md) | [1,105 d](/filings/0000719955-26-000059.md) | [793](/filings/0000719955-26-000131.md) | [1,012](/filings/0000719955-26-000208.md) |
| Selling, general and administrative | $m | [507](/filings/0001628280-24-048978.md) | [591 d](/filings/0000719955-26-000059.md) | [478](/filings/0001628280-25-028196.md) | [526](/filings/0000719955-25-000010.md) | [513](/filings/0000719955-25-000049.md) | [635 d](/filings/0000719955-26-000059.md) | [475](/filings/0000719955-26-000131.md) | [537](/filings/0000719955-26-000208.md) | [549](/filings/0000719955-25-000049.md) | [627 d](/filings/0000719955-26-000059.md) | [502](/filings/0000719955-26-000131.md) | [563](/filings/0000719955-26-000208.md) |
| Operating income | $m | [315](/filings/0001628280-24-048978.md) | [458 d](/filings/0000719955-26-000059.md) | [317](/filings/0001628280-25-028196.md) | [278](/filings/0000719955-25-000010.md) | [305](/filings/0000719955-25-000049.md) | [530 d](/filings/0000719955-26-000059.md) | [291](/filings/0000719955-26-000131.md) | [328](/filings/0000719955-26-000208.md) | [319](/filings/0000719955-25-000049.md) | [478 d](/filings/0000719955-26-000059.md) | [292](/filings/0000719955-26-000131.md) | [449](/filings/0000719955-26-000208.md) |
| Income tax | $m | [85.0](/filings/0001628280-24-048978.md) | [117 d](/filings/0000719955-26-000059.md) | [72.7](/filings/0001628280-25-028196.md) | [76.3](/filings/0000719955-25-000010.md) | [79.6](/filings/0000719955-25-000049.md) | [132 d](/filings/0000719955-26-000059.md) | [69.0](/filings/0000719955-26-000131.md) | [89.6](/filings/0000719955-26-000208.md) | [87.3](/filings/0000719955-25-000049.md) | [118 d](/filings/0000719955-26-000059.md) | [67.2](/filings/0000719955-26-000131.md) | [123](/filings/0000719955-26-000208.md) |
| Net income | $m | [237](/filings/0001628280-24-048978.md) | [354 d](/filings/0000719955-26-000059.md) | [260](/filings/0000719955-25-000049.md) | [217](/filings/0000719955-25-000049.md) | [237](/filings/0000719955-25-000049.md) | [411 d](/filings/0000719955-26-000059.md) | [231](/filings/0000719955-26-000208.md) | [248](/filings/0000719955-26-000208.md) | [242](/filings/0000719955-25-000049.md) | [368 d](/filings/0000719955-26-000059.md) | [231](/filings/0000719955-26-000208.md) | [338](/filings/0000719955-26-000208.md) |
| Diluted EPS | $ per share | [1.83](/filings/0001628280-24-048978.md) | not reported | [1.99](/filings/0001628280-25-028196.md) | [1.67](/filings/0000719955-25-000010.md) | [1.87](/filings/0000719955-25-000049.md) | not reported | [1.85](/filings/0000719955-26-000131.md) | [2.00](/filings/0000719955-26-000208.md) | [1.96](/filings/0000719955-25-000049.md) | not reported | [1.93](/filings/0000719955-26-000131.md) | [2.84](/filings/0000719955-26-000208.md) |
| Basic EPS | $ per share | [1.85](/filings/0001628280-24-048978.md) | not reported | [2.03](/filings/0001628280-25-028196.md) | [1.69](/filings/0000719955-25-000010.md) | [1.89](/filings/0000719955-25-000049.md) | not reported | [1.88](/filings/0000719955-26-000131.md) | [2.03](/filings/0000719955-26-000208.md) | [1.99](/filings/0000719955-25-000049.md) | not reported | [1.95](/filings/0000719955-26-000131.md) | [2.87](/filings/0000719955-26-000208.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-29) | FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [699](/filings/0001628280-24-048978.md) | [1,262](/filings/0001628280-25-015037.md) | [1,255](/filings/0001628280-25-028196.md) | [1,265](/filings/0000719955-25-000010.md) | [827](/filings/0000719955-25-000049.md) | [1,213](/filings/0000719955-26-000059.md) | [1,047](/filings/0000719955-26-000131.md) | [986](/filings/0000719955-26-000208.md) | [885](/filings/0000719955-25-000049.md) | [1,020](/filings/0000719955-26-000208.md) | [652](/filings/0000719955-26-000131.md) | [1,029](/filings/0000719955-26-000208.md) |
| Current assets | $m | [2,347](/filings/0001628280-24-048978.md) | [2,720](/filings/0001628280-25-015037.md) | [2,667](/filings/0001628280-25-028196.md) | [2,715](/filings/0000719955-25-000010.md) | [2,433](/filings/0000719955-25-000049.md) | [2,755](/filings/0000719955-26-000059.md) | [2,597](/filings/0000719955-26-000131.md) | [2,656](/filings/0000719955-26-000208.md) | [2,647](/filings/0000719955-25-000049.md) | [2,713](/filings/0000719955-26-000208.md) | [2,346](/filings/0000719955-26-000131.md) | [2,747](/filings/0000719955-26-000208.md) |
| Total assets | $m | [4,884](/filings/0001628280-24-048978.md) | [5,274](/filings/0001628280-25-015037.md) | [5,153](/filings/0001628280-25-028196.md) | [5,182](/filings/0000719955-25-000010.md) | [4,914](/filings/0000719955-25-000049.md) | [5,302](/filings/0000719955-26-000059.md) | [5,157](/filings/0000719955-26-000131.md) | [5,228](/filings/0000719955-26-000208.md) | [5,311](/filings/0000719955-25-000049.md) | [5,412](/filings/0000719955-26-000208.md) | [5,060](/filings/0000719955-26-000131.md) | [5,506](/filings/0000719955-26-000208.md) |
| Current liabilities | $m | [1,789](/filings/0001628280-24-048978.md) | [1,880](/filings/0001628280-25-015037.md) | [1,719](/filings/0001628280-25-028196.md) | [1,743](/filings/0000719955-25-000010.md) | [1,817](/filings/0000719955-25-000049.md) | [1,912](/filings/0000719955-26-000059.md) | [1,722](/filings/0000719955-26-000131.md) | [1,766](/filings/0000719955-26-000208.md) | [1,855](/filings/0000719955-25-000049.md) | [1,954](/filings/0000719955-26-000208.md) | [1,763](/filings/0000719955-26-000131.md) | [1,899](/filings/0000719955-26-000208.md) |
| Total liabilities | $m | [3,071](/filings/0001628280-24-048978.md) | [3,146](/filings/0001628280-25-015037.md) | [2,948](/filings/0001628280-25-028196.md) | [2,946](/filings/0000719955-25-000010.md) | [3,034](/filings/0000719955-25-000049.md) | [3,159](/filings/0000719955-26-000059.md) | [2,996](/filings/0000719955-26-000131.md) | [3,079](/filings/0000719955-26-000208.md) | [3,243](/filings/0000719955-25-000049.md) | [3,329](/filings/0000719955-26-000208.md) | [3,190](/filings/0000719955-26-000131.md) | [3,365](/filings/0000719955-26-000208.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,813](/filings/0001628280-24-048978.md) | [2,128](/filings/0000719955-26-000059.md) | [2,204](/filings/0000719955-25-000049.md) | [2,236](/filings/0000719955-25-000049.md) | [1,881](/filings/0000719955-25-000049.md) | [2,142](/filings/0000719955-26-000208.md) | [2,161](/filings/0000719955-26-000208.md) | [2,150](/filings/0000719955-26-000208.md) | [2,068](/filings/0000719955-25-000049.md) | [2,083](/filings/0000719955-26-000208.md) | [1,870](/filings/0000719955-26-000208.md) | [2,141](/filings/0000719955-26-000208.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q4 FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q4 FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [290 d](/filings/0001628280-24-048978.md) | [675 d](/filings/0000719955-26-000059.md) | [227](/filings/0001628280-25-028196.md) | [246 d](/filings/0000719955-25-000010.md) | [253 d](/filings/0000719955-25-000049.md) | [633 d](/filings/0000719955-26-000059.md) | [119](/filings/0000719955-26-000131.md) | [283 d](/filings/0000719955-26-000208.md) | [316 d](/filings/0000719955-25-000049.md) | [597 d](/filings/0000719955-26-000059.md) | [156](/filings/0000719955-26-000131.md) | [540 d](/filings/0000719955-26-000208.md) |
| Capital expenditure | $m | [42.0 d](/filings/0001628280-24-048978.md) | [53.6 d](/filings/0000719955-26-000059.md) | [39.5](/filings/0001628280-25-028196.md) | [31.4 d](/filings/0000719955-25-000010.md) | [83.4 d](/filings/0000719955-25-000049.md) | [67.2 d](/filings/0000719955-26-000059.md) | [58.3](/filings/0000719955-26-000131.md) | [52.0 d](/filings/0000719955-26-000208.md) | [68.2 d](/filings/0000719955-25-000049.md) | [80.9 d](/filings/0000719955-26-000059.md) | [57.7](/filings/0000719955-26-000131.md) | [58.7 d](/filings/0000719955-26-000208.md) |
| Dividends paid | $m | [57.9 d](/filings/0001628280-24-048978.md) | [57.9 d](/filings/0000719955-26-000059.md) | [62.9](/filings/0001628280-25-028196.md) | [72.9 d](/filings/0000719955-25-000010.md) | [73.1 d](/filings/0000719955-25-000049.md) | [71.2 d](/filings/0000719955-26-000059.md) | [74.7](/filings/0000719955-26-000131.md) | [81.3 d](/filings/0000719955-26-000208.md) | [80.6 d](/filings/0000719955-25-000049.md) | [79.9 d](/filings/0000719955-26-000059.md) | [85.6](/filings/0000719955-26-000131.md) | [89.9 d](/filings/0000719955-26-000208.md) |
| Share repurchases | $m | [3.0](/filings/0001628280-24-048978.md) | [0.0 d](/filings/0000719955-26-000059.md) | [43.8](/filings/0001628280-25-028196.md) | [130](/filings/0000719955-25-000010.md) | [534](/filings/0000719955-25-000049.md) | [100 d](/filings/0000719955-26-000059.md) | [90.0](/filings/0000719955-26-000131.md) | [199](/filings/0000719955-26-000208.md) | [267](/filings/0000719955-25-000049.md) | [298 d](/filings/0000719955-26-000059.md) | [288](/filings/0000719955-26-000131.md) | [0.0 d](/filings/0000719955-26-000208.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-30) | Q1 FY2023 (2023-04-30) | Q2 FY2023 (2023-07-30) | Q3 FY2023 (2023-10-29) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.6](/filings/0001628280-23-040136.md) | [66.7](/filings/0001628280-24-025227.md) | [129](/filings/0001628280-24-038362.md) | [130](/filings/0001628280-24-048978.md) | [131](/filings/0001628280-25-028196.md) | [130](/filings/0000719955-25-000010.md) | [127](/filings/0000719955-25-000049.md) | [125](/filings/0000719955-26-000131.md) | [124](/filings/0000719955-26-000208.md) | [123](/filings/0000719955-25-000049.md) | [120](/filings/0000719955-26-000131.md) | [119](/filings/0000719955-26-000208.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 117,779,173 at 2026-08-23, from the cover of the [10-Q filed 2026-08-28](/filings/0000719955-26-000208.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.